|
Volumn 87, Issue 6, 2001, Pages 848-854
|
Safety of oral nicorandil before coronary artery bypass graft surgery
a a a a a a a,b a c a |
Author keywords
Cardiovascular system, effects; Heart, myocardial function; Pharmacology, nicorandil; Surgery, cardiopulmonary bypass
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
ADRENALIN;
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CREATINE KINASE;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EMLA;
EPHEDRINE;
FENTANYL;
HEART ENZYME;
HETASTARCH;
HYDROXYZINE;
ISOFLURANE;
MIDAZOLAM;
MORPHINE;
NICARDIPINE;
NICORANDIL;
PANCURONIUM;
PLACEBO;
PROPACETAMOL;
TRIMETAZIDINE;
TROPONIN I;
URAPIDIL;
VASOACTIVE AGENT;
VASODILATOR AGENT;
VERAPAMIL;
ADULT;
ANESTHESIA;
ANGINA PECTORIS;
AORTA;
ARTERY CATHETERIZATION;
ARTICLE;
ARTIFICIAL VENTILATION;
CARDIOPULMONARY BYPASS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CREATINE KINASE BLOOD LEVEL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG MECHANISM;
DRUG SAFETY;
FEMALE;
HEART HEMODYNAMICS;
HEART INFARCTION;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
HYPOTENSION;
INTENSIVE CARE UNIT;
MALE;
MEDICAL RECORD;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
ST SEGMENT;
TACHYCARDIA;
|
EID: 17944377189
PISSN: 00070912
EISSN: None
Source Type: Journal
DOI: 10.1093/bja/87.6.848 Document Type: Article |
Times cited : (7)
|
References (28)
|